Ignite Creation Date:
2024-07-17 @ 10:45 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06470373
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-24
First Post:
2024-06-11
Brief Title:
A Phase 3 Clinical Trial to Compare RBS-001 to Eylea in Subjects With Neovascular Age-Related Macular Degeneration
Sponsor:
Organization:
Rophibio Inc